Belumosudil (Rezurock)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Belumosudil (Rezurock), covering 2025-05-02 to 2025-05-02. Get the full timeline:
Most recent: Clinical Trial Update: Extended Treatment and Follow-up of Subjects Treated With Belumosudil in Study KD025-208 or Study KD025-213 [Phase 2]